The Xeljanz Timeline
2012: The FDA approved Xeljanz for rheumatoid arthritis patients who were not responding to other available medications. 2017: The FDA approved Xeljanz as a treatment for psoriatic arthritis patients. 2018: The FDA approved Xeljanz as a treatment for ulcerative colitis patients. February 25, 2019: The FDA alerted the public to the Xeljanz safety clinical trial…